ORGANOGENESIS HOLDINGS INC. Shares Outstanding (Cover Page)
ORGANOGENESIS HOLDINGS INC. (ORGO) had Shares Outstanding (Cover Page) of 128.67 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 128.67M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 128.67M shares.
- 2026-02-23: Entity Common Stock, Shares Outstanding 128.64M shares.
- 2025-10-30: Entity Common Stock, Shares Outstanding 126.91M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 128.67M shares 10-Q · filed 2026-08-06 |
| 2026-04-30 | 128.67M shares 10-Q · filed 2026-05-07 |
| 2026-02-23 | 128.64M shares 10-K · filed 2026-02-26 |
| 2025-10-30 | 126.91M shares 10-Q · filed 2025-11-06 |
| 2025-07-31 | 126.86M shares 10-Q · filed 2025-08-07 |
| 2025-04-30 | 126.85M shares 10-Q · filed 2025-05-08 |
| 2025-04-28 | 126.85M shares 10-K/A · filed 2025-04-29 |
| 2025-02-24 | 126.83M shares 10-K · filed 2025-02-27 |
| 2024-11-05 | 132.58M shares 10-Q · filed 2024-11-12 |
| 2024-07-31 | 132.58M shares 10-Q · filed 2024-08-08 |
| 2024-04-30 | 132.57M shares 10-Q · filed 2024-05-09 |
| 2024-02-25 | 131.96M shares 10-K · filed 2024-02-29 |
| 2023-11-01 | 132.04M shares 10-Q · filed 2023-11-09 |
| 2023-08-01 | 131.31M shares 10-Q · filed 2023-08-09 |
| 2023-05-01 | 131.26M shares 10-Q · filed 2023-05-10 |
| 2023-02-15 | 131.18M shares 10-K · filed 2023-03-01 |
| 2022-11-01 | 130.92M shares 10-Q · filed 2022-11-09 |
| 2022-08-01 | 130.89M shares 10-Q · filed 2022-08-09 |
| 2022-05-01 | 129.13M shares 10-Q · filed 2022-05-10 |
| 2022-04-10 | 129.07M shares 10-K/A · filed 2022-04-29 |
| 2022-02-15 | 128.77M shares 10-K · filed 2022-03-01 |
| 2021-11-01 | 128.64M shares 10-Q · filed 2021-11-09 |
| 2021-08-01 | 128.58M shares 10-Q · filed 2021-08-09 |
| 2021-05-01 | 128.22M shares 10-Q · filed 2021-05-11 |
| 2021-02-28 | 127.99M shares 10-K · filed 2021-03-16 |
| 2020-11-01 | 107.79M shares 10-Q · filed 2020-11-09 |
| 2020-08-01 | 105.42M shares 10-Q · filed 2020-08-10 |
| 2020-05-01 | 106.11M shares 10-Q · filed 2020-05-11 |
| 2020-02-28 | 105.36M shares 10-K · filed 2020-03-09 |
| 2019-11-01 | 94.74M shares 10-Q · filed 2019-11-12 |
| 2019-08-01 | 91.34M shares 10-Q · filed 2019-08-09 |
| 2019-05-03 | 91.32M shares 10-Q · filed 2019-05-10 |
| 2019-03-01 | 92.01M shares 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |